Literature DB >> 3026782

In vivo association of [125I]-insulin with a cytosolic insulin-degrading enzyme: detection by covalent cross-linking and immunoprecipitation with a monoclonal antibody.

J Hari, K Shii, R A Roth.   

Abstract

A cytosolic insulin-degrading enzyme (Mr = 110,000) was found to be cross-linked to [125I]-insulin in intact human hepatoma cells, HepG2, incubated with the hormone and treated with the bifunctional cross-linker, disuccinimidyl suberate. The labeling of this protein was greatly increased by concurrent treatment of the cells with N-ethylmaleimide, to the extent that the amount of [125I]-insulin cross-linked to the enzyme in these cells was approximately 20 to 50% that cross-linked to the insulin receptor. The labeling of the insulin-degrading enzyme required the prior interaction of [125I]-insulin with its receptor as well as a temperature- and energy-dependent processing of the hormone. The present work therefore supports a role for this protease in the cellular processing of insulin.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3026782     DOI: 10.1210/endo-120-2-829

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  16 in total

1.  Purified recombinant insulin-degrading enzyme degrades amyloid beta-protein but does not promote its oligomerization.

Authors:  V Chesneau; K Vekrellis; M R Rosner; D J Selkoe
Journal:  Biochem J       Date:  2000-10-15       Impact factor: 3.857

2.  Mixed dimers of insulin-degrading enzyme reveal a cis activation mechanism.

Authors:  Eun Suk Song; David W Rodgers; Louis B Hersh
Journal:  J Biol Chem       Date:  2011-02-22       Impact factor: 5.157

3.  Identification of glutamate-169 as the third zinc-binding residue in proteinase III, a member of the family of insulin-degrading enzymes.

Authors:  A B Becker; R A Roth
Journal:  Biochem J       Date:  1993-05-15       Impact factor: 3.857

4.  Anion activation site of insulin-degrading enzyme.

Authors:  Nicholas Noinaj; Eun Suk Song; Sonia Bhasin; Benjamin J Alper; Walter K Schmidt; Louis B Hersh; David W Rodgers
Journal:  J Biol Chem       Date:  2011-11-02       Impact factor: 5.157

5.  Degradation of soluble amyloid beta-peptides 1-40, 1-42, and the Dutch variant 1-40Q by insulin degrading enzyme from Alzheimer disease and control brains.

Authors:  A Pérez; L Morelli; J C Cresto; E M Castaño
Journal:  Neurochem Res       Date:  2000-02       Impact factor: 3.996

6.  The characterization of endosomal insulin degradation intermediates and their sequence of production.

Authors:  P J Seabright; G D Smith
Journal:  Biochem J       Date:  1996-12-15       Impact factor: 3.857

7.  A monomeric variant of insulin degrading enzyme (IDE) loses its regulatory properties.

Authors:  Eun Suk Song; David W Rodgers; Louis B Hersh
Journal:  PLoS One       Date:  2010-03-16       Impact factor: 3.240

8.  Purification of a protease in red blood cells that degrades oxidatively damaged haemoglobin.

Authors:  J M Fagan; L Waxman
Journal:  Biochem J       Date:  1991-08-01       Impact factor: 3.857

9.  Identification of a protein associated with p21ras by chemical crosslinking.

Authors:  J de Gunzburg; R Riehl; R A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

10.  In vivo identification of the outer membrane protein OmcA-MtrC interaction network in Shewanella oneidensis MR-1 cells using novel hydrophobic chemical cross-linkers.

Authors:  Haizhen Zhang; Xiaoting Tang; Gerhard R Munske; Natalia Zakharova; Li Yang; Chunxiang Zheng; Megan A Wolff; Nikola Tolic; Gordon A Anderson; Liang Shi; Matthew J Marshall; James K Fredrickson; James E Bruce
Journal:  J Proteome Res       Date:  2008-02-28       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.